Kais Zakharia to Protein Kinase Inhibitors
This is a "connection" page, showing publications Kais Zakharia has written about Protein Kinase Inhibitors.
Connection Strength
0.121
-
Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, Moser CD, Shaleh HM, Thornburgh SR, Walters I, Roberts LR. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling. PLoS One. 2014; 9(4):e92273.
Score: 0.095
-
Zakharia Y, Zakharia K, Rixe O. Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma. Expert Opin Drug Discov. 2015; 10(8):925-35.
Score: 0.026